3rd party tested ghk cu GHK-CU – Research Peptide GHK-CU COPPER PEPTIDE 5MG/10MG/50MG/100MG VIAL

Pen Dosage Chart Dosage & Protocols Variations Standard Research Protocol Dose: 0.25 + 0.5 mg (variant 5 + 5 mg pen = 15 clicks / variant 5 + 10 mg pen = 10 clicks) Duration: 8 12 weeks Frequency: 1 daily Cycle Interval: 4-week rest Goal / Description: Baseline GH and IGF-1 enhancement in research models Performance Study Protocol Dose: 0.5 + 1.0 mg (variant 5 + 5 mg pen = 30 clicks / variant 5 + 10 mg pen = 20 clicks) Duration: 8 12 weeks Frequency: 1 daily (evening) Cycle Interval: 8-week rest Goal / Description: Designed for muscle recovery and metabolic modulation experiments Every Other Day Protocol Dose: 0.5 + 0.5 mg (variant 5 + 5 mg pen = 20 clicks / variant 5 + 10 mg pen = 13 clicks) Duration: 8 12 weeks Frequency: Every Other Day Cycle Interval: 4-week rest Goal / Description: Pulsatile GH release pattern

Kandhaya-Pillai, R

Research is currently in progress to address some of these issues and, as mentioned, NICE guidelines for the diagnosis and management of vitamin B12 deficiency are in development

Jan 19 2021;16(1):12

Glycemic improvement: Marked HbA1c drops (about 2.0%) in adults with type 2 diabetes [3]

Additionally, significant associations were observed between single nucleotide variants in the NNMT gene and energy metabolism, obesity, T2D, hyperlipidemia, and hypertension (Zhu et al., 2016